Published on in Vol 4, No 7 (2020): July
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/17373, first published
.
![A Companion App to Support Rheumatology Patients Treated with Certolizumab Pegol: Results From a Usability Study A Companion App to Support Rheumatology Patients Treated with Certolizumab Pegol: Results From a Usability Study](https://asset.jmir.pub/assets/50d7a81b53123c9679c33e8e14925cbf.png 480w,https://asset.jmir.pub/assets/50d7a81b53123c9679c33e8e14925cbf.png 960w,https://asset.jmir.pub/assets/50d7a81b53123c9679c33e8e14925cbf.png 1920w,https://asset.jmir.pub/assets/50d7a81b53123c9679c33e8e14925cbf.png 2500w)
1 UCB Pharma, Slough, United Kingdom
2 UCB Pharma, Brussels, Belgium
*all authors contributed equally